OpinionNovember 13, 2023
Newborn Genomic Screening Needs to Build the Evidence
With many large newborn genomic screening studies launching, we need to answer questions about cost, fairness and tangible benefits of a promising technology
Stories by Richard Scott
Richard Scott is interim CEO at Genomics England, clinical geneticist at Great Ormond Street Hospital and honorary associate professor at the UCL Great Ormond Street Institute of Child Health, London.